title: Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?
abstract: The inflammatory arthritis that develops in some patients subsequent to urogenital infection by the obligate intracellular bacterial pathogen Chlamydia trachomatis, and that induced subsequent to pulmonary infection with C. pneumoniae, both have proved difficult to treat in either their acute or chronic forms. Over the last two decades, molecular genetic and other studies of these pathogens have provided a good deal of information regarding their metabolic and genetic structures, as well as the detailed means by which they interact with their host cells. In turn, these insights have provided for the first time a window into the bases for treatment failures for the inflammatory arthritis. In this article we discuss the biological bases for those treatment failures, provide suggestions as to research directions that should allow improvement in treatment modalities, and speculate on how treatment regimens that currently show promise might be significantly improved over the near future using nanotechological means.
authors.affiliation: Department of Internal Medicine, Division of Rheumatology, University of South Florida, Tampa, FL, USA.
authors.forename: John D
authors.initials: JD
authors.lastname: Carter
authors.forename: Hervé C
authors.initials: HC
authors.lastname: Gérard
authors.forename: Judith A
authors.initials: JA
authors.lastname: Whittum-Hudson
authors.forename: Alan P
authors.initials: AP
authors.lastname: Hudson